NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,290 | +7.1% | 2,683 | +6.1% | 0.07% | +6.0% |
| Q2 2023 | $255,201 | +30.2% | 2,529 | +18.7% | 0.07% | +21.8% |
| Q1 2023 | $195,960 | +9.6% | 2,130 | +8.1% | 0.06% | +5.8% |
| Q4 2022 | $178,718 | +18.4% | 1,970 | -0.9% | 0.05% | +15.6% |
| Q3 2022 | $151,000 | +18.9% | 1,988 | +32.3% | 0.04% | +18.4% |
| Q2 2022 | $127,000 | +44.3% | 1,503 | +50.0% | 0.04% | +65.2% |
| Q1 2022 | $88,000 | +11.4% | 1,002 | +10.7% | 0.02% | +9.5% |
| Q4 2021 | $79,000 | +6.8% | 905 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $74,000 | -10.8% | 905 | 0.0% | 0.02% | -8.7% |
| Q2 2021 | $83,000 | +7.8% | 905 | 0.0% | 0.02% | +9.5% |
| Q1 2021 | $77,000 | -23.8% | 905 | -16.0% | 0.02% | -30.0% |
| Q4 2020 | $101,000 | +18.8% | 1,078 | 0.0% | 0.03% | +11.1% |
| Q3 2020 | $85,000 | – | 1,078 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |